Periprosthetic joint infection of megaprostheses for oncologic and non-oncologic indications—IMPLANT retention or removal? A retrospective cohort study of 50 cases
Abstract Background and purpose Periprosthetic joint infection (PJI) is a devastating but rare complication. Its incidence ranges between 1%–2% in primary arthroplasties. However, infection rates are much higher in megaprostheses (15%–43%). Revision of megaprostheses (MP) is a highly complex procedu...
Saved in:
| Main Authors: | Benjamin Schlossmacher, Elena Strasser, Vincent Lallinger, Florian Pohlig, Ruediger von Eisenhart-Rothe, Igor Lazic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Arthroplasty |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42836-025-00314-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mid-term results after DAIR for patients with acute periprosthetic joint infections of the hip or knee
by: Alberto Alfieri Zellner, et al.
Published: (2025-07-01) -
Long‐term outcome of periprosthetic joint infection following unicompartmental knee arthroplasty: A single‐centre case series
by: Kevin‐Arno Koch, et al.
Published: (2025-04-01) -
Periprosthetic humeral fractures after shoulder arthroplasty
by: Anna Behrens, et al.
Published: (2025-07-01) -
Analysis of the microbial landscape in patients with periprosthetic infection of the hip joint
by: Artem M. Ermakov, et al.
Published: (2025-06-01) -
Debridement, antibiotics, and implant retention in non‐oncological femoral megaprosthesis infections: minimum 5 year follow‐up
by: A. Asokan, et al.
Published: (2022-01-01)